1. B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia
    Shuangshuang Fan et al, 2023, European Journal of Medical Research CrossRef
  2. B7-H3 Immune Checkpoint Protein in Human Cancer
    Karine Flem-Karlsen et al, 2020, Current Medicinal Chemistry CrossRef
  3. B7-H3/CD276: An Emerging Cancer Immunotherapy
    Wu-Tong Zhou et al, 2021, Frontiers in Immunology CrossRef
  4. Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis
    Haohao sun et al, 2024, BMC Urology CrossRef
  5. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma
    Wanzun Lin et al, 2021, Frontiers in Immunology CrossRef
  6. Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
    Peng Ding et al, 2022, Frontiers in Immunology CrossRef
  7. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
    Yang-Hong Ni et al, 2020, Current Gene Therapy CrossRef
  8. Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
    Shenghua Zhan et al, 2020, Frontiers in Oncology CrossRef
  9. Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer
    Jia Li et al, 2024, Frontiers in Oncology CrossRef
  10. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors
    Petar Rasic et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
  11. Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
    Sebastian Chrétien et al, 2019, Cancers CrossRef
  12. The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review
    Noora Karim Ahangar et al, 2021, International Journal of Molecular Sciences CrossRef
  13. Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
    Jan P. Bogen et al, 2021, Frontiers in Oncology CrossRef
  14. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration
    Nah Ihm Kim et al, 2020, Pathobiology CrossRef
  15. Hub gene of disulfidptosis-related immune checkpoints in breast cancer
    Ye Wang et al, 2023, Medical Oncology CrossRef